Laser Therapy for Treating Hypertrophic Burn Scars in Children
Status: | Completed |
---|---|
Conditions: | Hospital, Orthopedic |
Therapuetic Areas: | Orthopedics / Podiatry, Other |
Healthy: | No |
Age Range: | 9 - 21 |
Updated: | 4/2/2016 |
Start Date: | May 2012 |
End Date: | January 2015 |
Contact: | Martha Lydon, RN,BS |
Email: | mlydon@shrinenet.org |
Phone: | 617-371-4808 |
Tunable-Dye Laser Therapy to Ameliorate Hypertrophic Scarring in Burned Children
Pulse-dye laser therapy has been used to treat the redness, tightness and discomfort of
hypertrophic scars resulting from burn injuries. To date the effectiveness of laser therapy
on children's burned scars has not been measured.
hypertrophic scars resulting from burn injuries. To date the effectiveness of laser therapy
on children's burned scars has not been measured.
In this study we hope to answer an important question in pediatric burn care: what are the
techniques whereby tunable-dye laser neo-vessel ablation is optimally employed to ameliorate
hypertrophic scars resulting from burn injuries in children? Hypertrophic scarring is
considered an adverse wound healing event that results in abnormal scar formation. This
scarring process is associated with pruritis and discomfort and can interfere with function
and aesthetics. Topical creams, massage, stretching and pressure are used as standard
treatments of burn scar formation. With the child serving as their own control, we want to
objectively measure the impact of PDL on burn scars in children. Variables of timing of
application, duration and number of sessions will all be collected.
techniques whereby tunable-dye laser neo-vessel ablation is optimally employed to ameliorate
hypertrophic scars resulting from burn injuries in children? Hypertrophic scarring is
considered an adverse wound healing event that results in abnormal scar formation. This
scarring process is associated with pruritis and discomfort and can interfere with function
and aesthetics. Topical creams, massage, stretching and pressure are used as standard
treatments of burn scar formation. With the child serving as their own control, we want to
objectively measure the impact of PDL on burn scars in children. Variables of timing of
application, duration and number of sessions will all be collected.
Inclusion Criteria:
- subjects 9 years and older to 21 years of age or younger with a second degree burn
with erythema and the potential for hypertrophic scarring to the thigh and or trunk.
- subject is clinically stable within 3 months of the burn injury.
- burn size of at least 15cm2 and able to be divided into equivalent halves (divided
along line of tension). Equivalent orientation distance from mobil joint with regard
to history,physical findings, proximity to tension producing forces and orientation.
- subjects in acute phase of burn injury generally less than one year from the time of
the burn injury at 2-3 months post burn when deemed appropriate for pressure therapy,
and have been evaluated as an appropriate candidate by a surgeon involved in this
study for inclusion.
- subjects can be included up to one year post burn if referred from another treatment
facility.
- no skin conditions that could potentially have an adverse effect on wound healing
- all race/ethnic groups
- children/guardians or significant others ability to speak English or Spanish and
respond to study questionnaires.
Exclusion Criteria:
- subjects less than 9 years old as this age group is more fragile.
- subjects with no second degree burn to thigh and or trunk
- subjects with chemical burns
- subjects at low risk for hypertrophic scaring (wounds that demonstrate fading
erythema at 9-12 weeks and wounds that are healed at less than 3 weeks are at low
risk for hypertrophic scaring). Vancouver scar scale pigmentation rating of 0 or 1,
vascularity rating of 0 or 1.
- TBSA greater than 50% as massive burns will confound results.
- potential life threatening injuries which would confound the effects of laser
treatment and complicate sequential administration of therapy (e.g.
shock,sepsis,inhalation therapies, brain injury).
- subjects with other inclusion criteria not met and evaluation by surgeon negative for
inclusion in study.
- children/guardians or significant others inability to speak English or Spanish and
respond to questionnaires.
- SUBJECTS WITH DOCUMENTED HYPERSENSITIVITY/ALLERGY TO AQUAPHOR,LIDOCAINE OR ANY OF
THEIR COMPONENTS.
We found this trial at
1
site
Click here to add this to my saved trials